Last Updated 1 December 2022.
This vaccine is approved.
Approved in 113 countries
26 trials in 25 countries
Non Replicating Viral Vector
Approved in 49 countries
6 trials in 1 country
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form